WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.

Quotes for WntResearch AB

Right Now

+/-
-0.385
%
-19,15%
Latest
1.625
High
1.9
Low
1.565
Volume
3 194 775
Turnover (SEK)
5 389 955
Value (MSEK)
85,8

Board

CEO

  • Peter Morsing

Chairman Of The Board

  • Gudrun Anstrén

Board

  • Jan Nilsson
  • Janna Sand-Dejmek
  • Martin Olovsson
  • Peter Ström
  • Tommy Andersson

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 11,91 11,91 2020-06-30
Nordnet Pensionsförsäkring 8,99 8,99 2020-06-30
Kjell Stenberg 3,03 3,03 2020-06-30
Tommy Andersson 2,05 2,05 2020-06-30
Gunvald Berger 1,52 1,52 2020-06-30
Lars-Erik Forsgårdh 1,33 1,33 2020-06-30
Swedbank Försäkring 0,71 0,71 2020-06-30
Leif Bertils 0,55 0,55 2020-06-30
Nils Qvarner 0,53 0,53 2020-06-30
Peter Nero 0,50 0,50 2020-06-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2020-11-12 Delårsrapport 2020-Q3